Hyperkalemic periodic paralysis
Also known as Gamstorp disease, Gamstorp episodic adynamy, HYPP, adynamia episodica hereditaria+12 more
Gamstorp disease, Gamstorp episodic adynamy, HYPP, adynamia episodica hereditaria, adynamia episodica hereditaria with or without myotonia, familial hyperPP, familial hyperkalemic periodic paralysis, familial hyperkalemic periodic paralysis (disorder) [ambiguous], hyperKPP, hyperPP, hyperkalemic PP, hyperkalemic periodic paralysis, type 2, normokalemic periodic paralysis, potassium-sensitive, primary hyperPP, primary hyperkalemic periodic paralysis, sodium channel muscle disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
Gamstorp disease, Gamstorp episodic adynamy, HYPP, adynamia episodica hereditaria, adynamia episodica hereditaria with or without myotonia, familial hyperPP, familial hyperkalemic periodic paralysis, familial hyperkalemic periodic paralysis (disorder) [ambiguous], hyperKPP, hyperPP, hyperkalemic PP, hyperkalemic periodic paralysis, type 2, normokalemic periodic paralysis, potassium-sensitive, primary hyperPP, primary hyperkalemic periodic paralysis, sodium channel muscle disease
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Related entities are derived from literature co-mention (studied together) — associative, not causal.